These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7370682)

  • 21. Clinical considerations in the management of the menopause: the endometrium.
    Whitehead MI; McQueen J; Minardi J; Campbell S
    Postgrad Med J; 1978; 54 Suppl 2():69-73. PubMed ID: 740583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.
    Wells M; Sturdee DW; Barlow DH; Ulrich LG; O'Brien K; Campbell MJ; Vessey MP; Bragg AJ
    BMJ; 2002 Aug; 325(7358):239. PubMed ID: 12153918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progestogens for endometrial protection in combined menopausal hormone therapy: A systematic review.
    Stute P; Walker LJ; Eicher A; Pavicic E; Kolokythas A; Theis S; von Gernler M; von Wolff M; Vollrath S
    Best Pract Res Clin Endocrinol Metab; 2024 Jan; 38(1):101815. PubMed ID: 37634998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of the endometrial effects of estrogens and progestins.
    Creasy GW; Kafrissen ME; Upmalis D
    Obstet Gynecol Surv; 1992 Sep; 47(9):654-78. PubMed ID: 1436909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens.
    Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA
    J Am Geriatr Soc; 1979 Sep; 27(9):389-94. PubMed ID: 469150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.
    Persson I; Adami HO; Bergkvist L; Lindgren A; Pettersson B; Hoover R; Schairer C
    BMJ; 1989 Jan; 298(6667):147-51. PubMed ID: 2538173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new combination of conjugated equine oestrogens and medroxyprogesterone for treatment of climacteric complaints.
    Cullberg G; Knutsson F; Mattsson LA
    Maturitas; 1984 Jul; 6(1):55-63. PubMed ID: 6088950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replacement hormone therapy in gonadal dysgenesis.
    Dewhurst CJ; de Koos EB; Haines RM
    Br J Obstet Gynaecol; 1975 May; 82(5):412-6. PubMed ID: 1137705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaginal bleeding patterns in women receiving hormone replacement therapy. Impact of various progestogen regimens.
    Thorneycroft IH; Gibbons WE
    J Reprod Med; 1999 Feb; 44(2 Suppl):209-14. PubMed ID: 11392034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. British Menopause Society tools for clinicians: Progestogens and endometrial protection.
    Hamoda H;
    Post Reprod Health; 2022 Mar; 28(1):40-46. PubMed ID: 34841960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevention of endometrial cancer in postmenopausal women with progestogens.
    Gambrell RD
    Maturitas; 1978 Sep; 1(2):107-12. PubMed ID: 755956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
    Ivanov S
    Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the levonorgestrel-releasing intrauterine system plus estrogen therapy in perimenopausal and postmenopausal women: systematic review and meta-analysis.
    Somboonporn W; Panna S; Temtanakitpaisan T; Kaewrudee S; Soontrapa S
    Menopause; 2011 Oct; 18(10):1060-6. PubMed ID: 21720280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial pattern in patients with primary hypoestrogenic amenorrhea receiving estrogen replacement therapy.
    Van Campenhout J; Choquette P; Vauclair R
    Obstet Gynecol; 1980 Sep; 56(3):349-55. PubMed ID: 7422173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progestogen modification of endometrial histology in menopasual women.
    Whitehead MI; Campbell S; Dyer G; Collins WP; Pryse-Davies J; Ryder TA; Rooney ML; McQueen J; King R
    Br Med J; 1978 Dec; 2(6152):1643-4. PubMed ID: 728765
    [No Abstract]   [Full Text] [Related]  

  • 36. Malignant and pseudomalignant hyperplasia adenomatosa of the endometrium in postmenopausal women treated with oestrogen.
    Ostergaard E
    Acta Obstet Gynecol Scand Suppl; 1974; 29():97-102. PubMed ID: 4526169
    [No Abstract]   [Full Text] [Related]  

  • 37. Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation.
    Hickey M; Higham JM; Fraser I
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD001895. PubMed ID: 22972055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyto-histologic evaluation of the endometrium in climacteric women at risk for endometrial carcinoma.
    de Aloysio D; Rocca G; Miliffi L
    Tumori; 1986 Aug; 72(4):431-7. PubMed ID: 3765124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone replacement therapy and the endometrium.
    Feeley KM; Wells M
    J Clin Pathol; 2001 Jun; 54(6):435-40. PubMed ID: 11376015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic aid of endometrium biopsy.
    van Bogaert LJ
    Gynecol Obstet Invest; 1979; 10(6):289-97. PubMed ID: 544370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.